NCT05989789 Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients Status COMPLETED Phase NA
NCT05964361 First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT05953337 Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05942560 Effects of CBT-Based Intervention Among Patients With Liver Cancer Status NOT_YET_RECRUITING Phase NA
NCT05931445 Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT05926336 The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action Status RECRUITING Phase PHASE4
NCT05886075 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors Status UNKNOWN Phase EARLY_PHASE1
NCT05872828 Cross-sectional Study of Chinese Liver Cancer Patients Status ENROLLING_BY_INVITATION Phase N/A
NCT05860374 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT05850130 Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients Status RECRUITING Phase NA
NCT05829057 The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 Status RECRUITING Phase PHASE1
NCT05816837 Displacement Distance and Stabilization Time for Liver Fiducial Marker Status UNKNOWN Phase N/A
NCT05806333 [18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity Status UNKNOWN Phase NA
NCT05804799 Liver CT Dose Reduction With Deep Learning Based Reconstruction Status COMPLETED Phase N/A
NCT05781581 A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection Status UNKNOWN Phase N/A
NCT05744219 Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial Status RECRUITING Phase PHASE3